Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects

Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects

OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.

Bibliographic Details
Main Authors: George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, the Canadian Carbapenem Discussion Group
Format: Article
Language:English
Published: Hindawi Limited 1998-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1998/831425
id doaj-05271c1cb6f742008391b2c991973ab2
record_format Article
spelling doaj-05271c1cb6f742008391b2c991973ab22020-11-24T22:45:52ZengHindawi LimitedCanadian Journal of Infectious Diseases1180-23321998-01-019421522810.1155/1998/831425Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse EffectsGeorge G Zhanel0Andrew E Simor1Lavern Vercaigne2Lionell Mandell3the Canadian Carbapenem Discussion GroupDepartments of Medicine and Microbiology, Health Sciences Centre and Faculties of Pharmacy and Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, CanadaDepartment of Pharmacy, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Infectious Diseases, McMaster University, Hamilton, Ontario, CanadaOBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.http://dx.doi.org/10.1155/1998/831425
collection DOAJ
language English
format Article
sources DOAJ
author George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
spellingShingle George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
Canadian Journal of Infectious Diseases
author_facet George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
author_sort George G Zhanel
title Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_short Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_full Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_fullStr Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_full_unstemmed Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_sort imipenem and meropenem: comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases
issn 1180-2332
publishDate 1998-01-01
description OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.
url http://dx.doi.org/10.1155/1998/831425
work_keys_str_mv AT georgegzhanel imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT andrewesimor imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT lavernvercaigne imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT lionellmandell imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT thecanadiancarbapenemdiscussiongroup imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
_version_ 1725687145191964672

Similar Items